R&D Collaboration with James Hutton Institute
02 October 2024|
Glass Pharms and the Advanced Plant Growth Centre at The James Hutton Institute are to conduct a medical cannabis research program, funded by UKRI’s Biotechnology and Biological Sciences Research Council (BBSRC).
Pictured from left: Olivier Dehon (CFO, Glass Pharms), Prof. Derek Stewart (James Hutton Institute), Richard Lewis (MD, Glass Pharms), Dr Raul Huertas (James Hutton Institute).
Share this post:
